Chamberlain, Alanna M.
Hade, Erinn M.
Haller, Irina V.
Horne, Benjamin D.
Benziger, Catherine P.
Lampert, Brent C.
Rasmusson, Kismet D.
Boddicker, Kimberly
Manemann, Sheila M.
Roger, VĂ©ronique L.
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (R01 HL120859, R01 HL120859, R01 HL120859)
Patient-Centered Outcomes Research Institute (CDRN-1501-26638, CDRN-1501-26638, CDRN-1501-26638, CDRN-1501-26638)
Article History
Received: 18 May 2023
Accepted: 5 April 2024
First Online: 24 April 2024
Declarations
:
: This study was approved by the Mayo Clinic Institutional Review Board (17-008773), which served as the IRB of record for the other 3 relying institutions participating in the LHSNet HF survey study. For this minimal risk study, the Mayo Clinic Institutional Review Board granted a waiver of written informed consent. All elements of informed consent were presented to participants in the cover letter that accompanied the survey packet in the mail. By completing and returning the survey, the Mayo Clinic Institutional Review Board considered this implied consent. The signed HIPAA form allowed linkage of the survey data to electronic health record data for patients who completed the survey. If a survey was returned without a signed HIPAA form, the survey was not used. All methods were carried out in accordance with relevant guidelines and regulations, and the Declaration of Helsinki.
: The authors declare no competing interests.
: Not applicable.